Q4 2019 BioInvent International AB Earnings Call Transcript
Thank you so much for the introduction and good morning, everybody. So we'll give a quick presentation, and basically what we are trying to do is to keep as much time as possible for Q&A.
I would like to start on slide 3, just to remind everybody about the company background. So obviously, we have at our core a very interesting discovery platform, which provides antibodies and targets. And as you might remember, we're using this in two ways. First of all, we did our own portfolio. And currently we have five programs in our portfolio, and we will come back to that later in more detail.
But also, we use this platform for collaborations. We have done some in the past. Last year, we had two interesting milestones: one with Mitsubishi Tanabe and another one with Takeda; and obviously also, two milestones with the Pfizer collaboration. And we will continue to have milestones also throughout this year.
So slide 4 is the very brief reintroduction of the platform. And I will only focus and highlight the unique features of this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |